Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer’s disease.
2025
Leuzy A, Bollack A, Pellegrino D, Teunissen CE, La Joie R, Rabinovici GD, Franzmeier N, Johnson K, Barkhof F, Shaw LM, Arkhipenko A, Schindler SE, Honig LS, Moscoso Rial A, Schöll M, Zetterberg H, Blennow K, Hansson O, Farrar G.
Alzheimers Dement. 2025 Mar;21(3):e14528. doi: 10.1002/alz.14528. PMID: 40042435 Free PMC article. Review.